ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2025

Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer.

N Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.